The introduction of lanreotide, in the form of Somatuline Autogel ® (SCRAS, Paris, France)—which does not require reconstitution before injection and is available in ready-to-use, prefilled ...
Adding the somatostatin analog lanreotide to the mTOR inhibitor everolimus significantly prolonged progression-free survival in patients with unresectable or recurrent gastroenteropancreatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback